Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $2.17 Million - $2.51 Million
25,000 New
25,000 $2.17 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $3.29 Million - $3.88 Million
40,000 New
40,000 $3.39 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $2.51 Million - $3.2 Million
35,000 New
35,000 $3.09 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Dsc Advisors, L.P. Portfolio

Follow Dsc Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Dsc Advisors, L.P. with notifications on news.